Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 8/20 | 0.63 |
| ▸ | TFPI | P10646 | 1/20 | 0.63 |
| ▸ | CCKBR | P32239 | 1/20 | 0.59 |
| ▸ | GLP1R | P43220 | 1/20 | 0.59 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.58 |
| ▸ | CALCR | P30988 | 3/20 | 0.56 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29967414 | 0.92 | PTH1R (0.63) | PTH1RTFPICCKBRGLP1RVIPR1 | |
| SCHEMBL31182762 | 0.92 | VIPR1 (0.62) | PTH1RTFPICCKBRGLP1RVIPR1 | |
| SCHEMBL30432639 | 0.92 | TFPI (0.59) | PTH1RTFPICCKBRGLP1RVIPR1 | |
| SCHEMBL29836383 | 0.91 | TFPI (0.60) | PTH1RTFPICCKBRGLP1RVIPR1 | |
| SCHEMBL29523535 | 0.91 | VIPR1 (0.69) | PTH1RTFPICCKBRGLP1RVIPR1 | |
| SCHEMBL30495662 | 0.91 | TFPI (0.69) | TFPICCKBRGLP1RVIPR1VIPR2 | |
| SCHEMBL29836305 | 0.91 | TFPI (0.63) | PTH1RTFPICCKBRGLP1RVIPR1 | |
| SCHEMBL30432173 | 0.90 | VIPR1 (0.69) | PTH1RTFPICCKBRGLP1RVIPR1 | |
| SCHEMBL29836281 | 0.90 | TFPI (0.66) | PTH1RTFPICCKBRGLP1RVIPR1 | |
| SCHEMBL29836425 | 0.90 | TFPI (0.66) | PTH1RTFPICCKBRGLP1RVIPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240350475-A1 | TRIGONELLINE MITIGATES CARDIOMYOPATHY CAUSED BY SARS-COV-2 SPIKE PROTEIN UNDER OBESITY | UNIVERSITY OF SOUTH CAROLINA (US) | 2024-10-24 | — | — | US | disclosed |